Insilico Medicine's MEN2501 Project Advances, Receives Milestone Payment from Menarini
Shanghai, China, February 3, 2026 — Insilico Medicine, a generative artificial intelligence-driven c...
China-Finland Collaboration Deepens: Biogenesys Co., Ltd. Partners with Finnish Pharma to Advance CGT Projects
On the evening of January 25, 2026, Finnish Prime Minister Petteri Orpo hosted a reception at the Fi...
AI and Integrated Platforms Propel Healthcare Payment Processes Towards Intelligent, Preventive Transformation
Currently, the healthcare payment sector faces dual challenges of cost control and payment accuracy....
Artificial Intelligence Seen as a Potential Aid to Bridge Gaps in Women's Health Services
Recent industry analysis indicates that artificial intelligence technology shows potential in improv...
Indigenization of China's High-End Medical Equipment: CGN Develops Proton Therapy System
CGN's "Hezhi®" Proton Therapy System was featured in the "Building the Foundation f...
Establishment of Cell Therapy Center at Guangdong Second Provincial General Hospital in China Promotes Precision Treatment for Hematologic Diseases
Recently, the Cell Therapy Center of the Hematology Department at Guangdong Second Provincial Genera...
Biopharmaceutical Company Mendra Completes $82 Million Series A Funding to Accelerate Rare Disease Treatment R&D
Mendra, a biopharmaceutical company headquartered in San Francisco, USA, recently announced its offi...
Aqneursa Approved by EU for Neurological Treatment
IntraBio, a biopharmaceutical company based in Texas, USA, recently announced that its drug Aqneursa...
Intuitive Surgical Exceeds Expectations in Q4 2025 Performance
The global surgical robot manufacturer Intuitive Surgical recently released its Q4 2025 earnings rep...
Infinitopes Completes Second Seed Funding Round to Accelerate Esophageal Cancer Vaccine Clinical Trial
UK-based cancer vaccine biotechnology company Infinitopes recently announced the successful completi...
Novavax Enters into Significant Licensing Agreement with Pfizer
Shares of the American biotechnology company Novavax rose 9% to $8.72 as of January 20. This increas...
Ipsen's IPN60340 Receives FDA Breakthrough Therapy Designation for Acute Myeloid Leukemia
The U.S. Food and Drug Administration (FDA) recently granted Breakthrough Therapy Designation (BTD) ...
ImmunityBio Receives Saudi Approval for Anktiva's New Therapy in Lung Cancer Treatment
New developments have emerged from the American immunotherapy company ImmunityBio. The Saudi Food an...
GSK and Noetik Partner to Accelerate Oncology Drug Development
Artificial intelligence-based biotechnology company Noetik announced a five-year strategic collabora...
Johnson & Johnson Reaches Agreement with U.S. Government on Drug Price Cuts in Exchange for Tariff Exemptions
On January 8, Johnson & Johnson announced that it had reached an agreement with the Trump administra...
U.S. Food and Drug Administration (FDA) Approves Omeros' New Drug Yartemlea for the Treatment of Transplant Complication TA-TMA
Wedoany.com Report-Dec.31, The U.S. Food and Drug Administration (FDA) has officially approved Yarte...
Mabwell's Adalimumab Injection Approved for Marketing in Indonesia
Wedoany.com Report-Dec.31, Mabwell (688062.SH), an innovative biopharmaceutical company with a full ...
Osaikang Pharma and Adlai Nortye Enter into License Agreement for Type 1 Innovative Drug AN9025 Project
Wedoany.com Report-Dec.30, Osaikang announced that its subsidiary Jiangsu Osaikang Pharmaceutical Co...
Ipsen Outlays $1BN for China-Based Simcere’s Preclinical ADC
Wedoany.com Report-Dec.28, Ipsen has entered into an exclusive licensing agreement with Simcere Zaim...
China’s Jacobio Inks Immuno-Oncology Deal Worth $1.9 B With AstraZeneca
Wedoany.com Report-Dec.26, China-based Jacobio Pharma (1167.HK) has entered into a global exclusive ...
Asahi Kasei Pharma to Relocate Global R&D Hub to Shonan Ipark in Japan
Wedoany.com Report-Dec.26, Asahi Kasei Pharma Corporation has announced plans to relocate its R&...
US FDA Approves Omeros’ Drug to Treat Dangerous Transplant Complication
Wedoany.com Report-Dec.25, Omeros Corporation announced on Wednesday that the U.S. Food and Drug Adm...
Sanofi Pushes Ahead on Adult Vaccines With $2.2 Billion Dynavax Deal
Wedoany.com Report-Dec.25, Sanofi announced on Wednesday, December 24, 2025, that it has entered int...
Agios Pharma Shares Jump as US FDA Expands Approval for Blood Disorder Drug
Wedoany.com Report-Dec.25, Agios Pharmaceuticals announced late on Tuesday that the U.S. Food and Dr...
Sinocare Receives Medical Device Registration Certificates for Multiple Products
Sinocare announced on December 23 that its Blood Glucose, Uric Acid, and Blood Ketone Analyzer, Bloo...
US Health Agency Unveils Weight-Loss Drug Coverage Model
Wedoany.com Report-Dec.24, The U.S. Centers for Medicare and Medicaid Services announced a voluntary...
Novo Nordisk Wins US Approval for Weight-Loss Pill
Wedoany.com Report-Dec.24, The U.S. Food and Drug Administration approved Novo Nordisk's oral weigh...
Novo Nordisk Shares Jump After US Approves Wegovy Pill
Wedoany.com Report-Dec.24, Novo Nordisk shares rose significantly on Tuesday following the U.S. Food...
GSK to Lower Drug Prices
Wedoany.com Report-Dec.22, GSK plc has concluded an agreement with the United States government to r...
Emcure Launches Poviztra, Second Brand of Novo Nordisk’s Weightloss Drug Wegovy
Wedoany.com Report-Dec.22, Emcure Pharmaceuticals has commercially launched Poviztra, the second bra...